As multi-state operators (MSOs) continue their rise in market appreciation and gain more attention from marijuana investors, a key metric for these companies is in which states do they operate.

Due to the continued search for growth-oriented plays in the marijuana public market, investors have turned their attention to the US cannabis industry.

Because of the federal illegality of cannabis and its derivatives, companies only have access to consumers in states that moved forward with legalization policies for the medical and, in some cases, even recreational space.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Here the Investing News Network (INN) offers a closer look at some of the states that companies and analysts are observing closely for growth.

These MSOs pursue the acquisition and operation of cannabis assets in legal states, including processing and growing facilities, networks of physical retail stores and lines of branded products.

“With some of these multi-state operators, no question they are taking up some quite a bit of market share pretty quickly,” Korey Bauer, managing director with Foothill Capital Management and portfolio manager of the Cannabis Growth Fund, previously told INN.

A separating factor from the US market compared to other legal marijuana jurisdictions, is that since each state has decided or allowed voters through ballot measures to decide when to implement marijuana laws, that means states have different timelines and different ways to set up their programs.

As previously indicated, some states have moved forward with an initial medical program, while others have gone as far as to allow recreational sales on some level.

Currently 10 states have fully legalized recreational marijuana use, while 33 states have already opened the doors to a medical program.

In 2018, Forbes wrote the following states were ones to watch in terms of legalization policies moving forward in 2019: Connecticut, Illinois, Minnesota, New Hampshire, New Jersey, New Mexico, New York, Rhode Island and Vermont.

Nawan Butt, portfolio manager with Purpose Investment, told INN that investors need to consider the states an MSO may be located or looking to expand into before investing.

“Illinois, Michigan, Ohio, Pennsylvania the rust belt essentially is very, very attractive and anybody who’s already placed there in the medical program does have an advantage of going into the recreational programs that come out,” Butt said.

Additionally, he explained when evaluating MSOs and which states they are in, the issue of licenses must be examined.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

A vibrant and diverse market such as California may sound like a solid expansion point for an MSO but in reality the market has been diluted due to an open system. Instead, Butt prefers states in which the market is just opening up.

“Having more than 100 direct cultivators, producers dispensaries within one of these states can cause a high-density and then a high-competition as well,” he said.

Here are some states that experts and companies have on the come up for investors to know.

Florida

The Sunshine State offers investors an emerging marijuana market that currently only allows for medical sales through dispensaries.

George Scorsis, former CEO of Liberty Health Sciences (CSE:LHS,OTCQX:LHSIF), previously told INN he expected to see a vote on adult-use sales in the 2020 state elections.

During the Canaccord Genuity Group’s (TSX:CF) “Growth Investor Day,” Trulieve Cannabis (CSE:TRUL,OTC Pink:TCNNF) CEO Kim Rivers told the audience she is not expecting to see the issue picked up in 2020 but rather in the 2024 elections.

As part of a research note on the state of the US cannabis market, Neal Gilmer, analyst with Haywood Securities, wrote Florida was one of the more attractive states in the US.

“The state is in the early stages of adoption and we believe will continue to support strong growth metrics as the medical program continues to evolve,” Gilmer wrote.

Fellow analyst Matt Bottomley, a director with equity research at Canaccord, said during the “Growth Investor Day” Florida was one of the most attractive markets in the US.

Pennsylvania

Despite only opening with a medical cannabis framework, Pennsylvania has quickly risen in the attention from the market.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

“Pennsylvania’s medical marijuana program is an unqualified success and has been the best state that’s ever had a program rollout,” Andrew Blasco, the Pennsylvania Cannabis Coalition executive director told The Inquirer. “Our rate of registering patients has been better than any other across the country.”

Blasco said the existing current dispensaries in the state, could quickly start the sales for recreational items.

During the Canaccord investor event, the management team for Cresco Labs (CSE:CL,OTC Pink:CRLBF) indicated Pennsylvania, along with Florida, was one of the fastest growing medical markets in the US they had seen.

The state is currently gauging citizen interest on a reform to allow recreational sales of cannabis.

New Jersey

New Jersey has attracted the attention of MSOs thanks to its rapidly emerging medical space, and the promise for an incoming recreational program.

In March, New Jersey lawmakers established a plan for the opening of recreational sales. The Cannabis Regulatory Commission of New Jersey would be tasked with overseeing the industry and its licenses if the bill is approved.

Recently, the state increased the number of licenses for medical producers allowed to sell product.

As a result of an US$850 million all stock acquisition of a private MSO, Harvest Health & Recreation (CSE:HARV,OTCQX:HRVSF) announced New Jersey was one of the top markets it had gained access to.

Investor takeaway

The marijuana business in the US is expanding and gaining more popularity as these cannabis companies pursuing various assets reach the public space.

Investors looking to add some of MSOs to their portfolios have to evaluate the states in which the company operates and which markets offer the most growth potential, as the US continues to open the doors to marijuana.


INNdepth

Want more details? Check out these articles for more INNdepth coverage.

Want an overview of investing in cannabis stocks? Check Investing in the Cannabis Industry


Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in contributed article. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Matica Enterprises Inc. (CSE: MMJ) (FSE: 39N) (OTCQB: MMJFF) (“Matica” or the “Company”) is pleased to announce that, in connection with the previously announced share consolidation on a thirty (30) for one (1) basis (the “Consolidation”), the Company will be changing its name to West Island Brands Inc. (the “Name Change”).

The common shares are scheduled to begin trading on a post-consolidation basis at market open on October 20, 2021 under the stock symbol “WIB”. The new CUSIP number will be 953400108 and the new ISIN number will be CA9534001081. Following the Consolidation, the Company will have approximately 10,712,484 common shares issued and outstanding.

Keep reading... Show less

In the cannabis space this week, a popular beverage maker hired a new executive in hopes of pursuing opportunities in the cannabis drink industry.

Meanwhile, Canopy Growth (NASDAQ:CGC,TSX:WEED) announced a fresh acquisition agreement for a partner designed to boost its presence in a potentially available US adult-use cannabis market.

Keep reading... Show less

Via InvestorWireIBN (“InvestorBrandNetwork”), a multifaceted financial news and publishing company, today announces that it will be collaborating with Microdose Psychedelic Insights for the Psych e delic Capital: October 2021 Conference which is set to be held in an entirely virtual format on Oct. 28, 2021.

The Psychedelic Capital: October Conference is set to be a virtual event, covering the most innovative and cutting-edge companies, latest IPOs, newest opportunities and deepest insights into the global psychedelic industry. From exploring ongoing governmental policy shifts to commercial product breakthroughs, the conference will serve to educate attendees on the potential uses and benefits attached to psychedelics in today’s environment.

Keep reading... Show less

 Adastra Holdings Ltd. (formerly Phyto Extractions Inc.) (CSE: XTRX) (FRA: D2EP) (“Adastra” or the “Company”) today announced positive operational and financial developments as the Company continues to pursue its mission to be a leader in the development and manufacture of pharma-quality, cannabis API and derivative products. These developments include record shipments in September, product portfolio expansion, and continued progress with Health Canada regarding its Controlled Substances Dealers License application.

Record September Shipments
Adastra shipped 68,272 consumer-packaged units and 20,000g of bulk extract in September compared to 41,571 units in September 2020 , a 64% increase year over year.

Keep reading... Show less

Matica Enterprises Inc. (CSE: MMJ) (FSE: 39N) (OTCQB: MMJFF) (“Matica” or the “Company”) is pleased to announce that, pursuant to a director’s resolution, the Company will be consolidating its issued and outstanding share capital on the basis of every thirty (30) old Common Shares being consolidated into one (1) new Common Share (the “Share Consolidation”). Any fractional shares remaining after giving effect to the Share Consolidation will be cancelled.

As a result, the outstanding Common Shares of the Company will be reduced to approximately 10,712,484. The Company has no other securities outstanding.

Keep reading... Show less